Company: Sanofi ($SNY)
Drug delivered: epinephrine
Why it's important: Sanofi makes our list with its January launch of an epinephrine pen that literally talks patients through an emergency injection. In 70% of cases that called for an epeniphrine shot, a patient's or caregiver's unease with the process led to either improper use of the needle or none at all, according to a National Institutes of Health report.
Sanofi's Auvi-Q, a prescription epinephrine injector, instructs the user via a recorded voice to hold the needle in the correct position and counts down as the injection is completed. In developing the cellphone-sized device, Sanofi took into account patients' needs and feedback to make the Auvi-Q a device worth watching.
Sanofi launches 'talking' emergency epinephrine injector
Sanofi epinephrine device guides users with voice and written instructions
EpiPen update boasts user protection